Methylprednisolone hemisuccinate Completed Phase 2 Trials for Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities / Intraocular Lymphoma / Recurrent Adult Non-Hodgkin Lymphoma / Secondary Myelodysplastic Syndromes / Recurrent Mantle Cell Lymphoma / Recurrent Adult Diffuse Large Cell Lymphoma / Adult Acute Myeloid Leukemia With T(8;21)(q22;q22) / Childhood Acute Lymphoblastic Leukemia in Remission / Refractory Multiple Myeloma / Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue / Adult Erythroleukemia (M6a) / Recurrent Grade 2 Follicular Lymphoma / Recurrent Adult Diffuse Mixed Cell Lymphoma / Adult Acute Myelomonocytic Leukemia (M4) / Peripheral T-Cell Lymphoma (PTCL) / Childhood Acute Myeloid Leukemia in Remission / Relapsing Chronic Myelogenous Leukemia / Burkitt's Lymphoma / Adult Acute Promyelocytic Leukemia (M3) / Recurrent Marginal Zone Lymphoma / Childhood Acute Myelomonocytic Leukemia (M4) / Childhood Acute Myeloblastic Leukemia Without Maturation (M1) / De Novo Myelodysplastic Syndromes / Adult Acute Myeloblastic Leukemia With Maturation (M2) / Testicular Lymphoma / Recurrent Adult Burkitt Lymphoma / Angioimmunoblastic T-Cell Lymphoma / Previously Treated Myelodysplastic Syndromes / Childhood Acute Myeloblastic Leukemia With Maturation (M2) / Small Intestine Lymphoma / Recurrent Grade 3 Follicular Lymphoma / Childhood Acute Megakaryocytic Leukemia (M7) / Childhood Acute Erythroleukemia (M6) / Adult Acute Megakaryoblastic Leukemia (M7) / Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma / Adult Acute Monocytic Leukemia (M5b) / Recurrent Adult T-Cell Leukemia/Lymphoma / Adult Nasal Type Extranodal NK/T-Cell Lymphoma / Recurrent Adult Hodgkin's Lymphoma / Chronic Phase Chronic Myelogenous Leukemia / Nodal marginal zone B-cell lymphomas / Recurrent Adult Diffuse Small Cleaved Cell Lymphoma / Recurrent Adult Acute Myeloid Leukemia / Childhood Acute Monocytic Leukemia (M5b) / Childhood Chronic Myelogenous Leukemia / Adult Acute Monoblastic Leukemia (M5a) / Recurrent Adult Immunoblastic Large Cell Lymphoma / Adult Acute Myeloid Leukemia in Remission / Post Transplant Lymphoproliferative Disorder / Recurrent Adult Lymphoblastic Lymphoma / Recurrent Grade 1 Follicular Lymphoma / Adult Acute Myeloblastic Leukemia Without Maturation (M1) / Hepatosplenic T-Cell Lymphoma / Splenic Marginal Zone Lymphoma / Accelerated Phase Chronic Myelogenous Leukemia / Adult Acute Myeloid Leukemia With T(16;16)(p13;q22) / Adult Pure Erythroid Leukemia (M6b) / Adult Acute Myeloid Leukemia With Del(5q) / Waldenström's Macroglobulinemia (WM) / Anaplastic Large-Cell Lymphoma / Recurrent Adult Acute Lymphoblastic Leukemia / Adult Acute Myeloid Leukemia With T(15;17)(q22;q12) / Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) / Cutaneous B-Cell Non-Hodgkin Lymphoma / Childhood Acute Monoblastic Leukemia (M5a) / Recurrent Small Lymphocytic Lymphoma / Recurrent Childhood Acute Lymphoblastic Leukemia / Recurrent Adult Grade III Lymphomatoid Granulomatosis / Recurrent Childhood Acute Myeloid Leukemia / Adult Acute Lymphoblastic Leukemia in Remission / Recurrent Mycosis Fungoides/Sezary Syndrome / Anaplastic Large Cell Lymphoma / Childhood Acute Promyelocytic Leukemia (M3) / Childhood Myelodysplastic Syndromes Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01177371High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma